Literature DB >> 8023796

Electrophysiologic findings in Fabry's disease with a short PR interval.

W T Pochis1, J T Litzow, B G King, D Kenny.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8023796     DOI： 10.1016/0002-9149(94)90106-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  13 in total

1.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

Review 2.  Cardiac manifestations in Fabry disease.

Authors:  A Linhart; J C Lubanda; T Palecek; J Bultas; D Karetová; J Ledvinová; M Elleder; M Aschermann
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

3.  Sisters with atypical Fabry's disease with complete atrioventricular block.

Authors:  Y Doi; G Toda; K Yano
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

4.  Early cardiac changes in children with anderson-fabry disease.

Authors:  Stepan Havranek; Ales Linhart; Zuzana Urbanova; Uma Ramaswami
Journal:  JIMD Rep       Date:  2013-04-02

Review 5.  Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.

Authors:  Brendan N Putko; Kevin Wen; Richard B Thompson; John Mullen; Miriam Shanks; Haran Yogasundaram; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

6.  Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.

Authors:  Jiwon Seo; Minji Kim; Geu-Ru Hong; Dae-Seong Kim; Jang-Won Son; In Jeong Cho; Chi Young Shim; Hyuk-Jae Chang; Jong-Won Ha; Namsik Chung
Journal:  J Hum Genet       Date:  2016-05-26       Impact factor: 3.172

Review 7.  Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment-A Systematic Review.

Authors:  Aidonis Rammos; Vasileios Meladinis; Georgios Vovas; Dimitrios Patsouras
Journal:  Radiol Res Pract       Date:  2017-11-15

8.  Cardiac Phenotype of Prehypertrophic Fabry Disease.

Authors:  Sabrina Nordin; Rebecca Kozor; Shanat Baig; Amna Abdel-Gadir; Katia Medina-Menacho; Stefania Rosmini; Gabriella Captur; Michel Tchan; Tarekegn Geberhiwot; Elaine Murphy; Robin Lachmann; Uma Ramaswami; Nicola C Edwards; Derralynn Hughes; Richard P Steeds; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2018-06       Impact factor: 7.792

Review 9.  Fabry disease and its cardiac involvement.

Authors:  Toru Kubo
Journal:  J Gen Fam Med       Date:  2017-05-08

10.  Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters.

Authors:  J W Koskenvuo; J J Hartiala; P Nuutila; R Kalliokoski; J S Viikari; E Engblom; M Penttinen; J Knuuti; I Mononen; I M Kantola
Journal:  J Inherit Metab Dis       Date:  2008-05-23       Impact factor: 4.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.